淺談子宮內膜癌

Overview of Endometrial Cancer

10.6224/JN.63.5.5

李佳純(Chia-Chun Li)；馮翠霞(Tsui-Hsia Feng)

子宮內膜癌 ； 危險因子 ； 醫療處置 ； endometrial cancer ； risk factors ； medical treatment

護理雜誌

63卷5期（2016 / 10 / 01）

5 - 11

繁體中文

子宮內膜癌是常見的婦科癌症，也是台灣女性十大癌症的第六位。危險因子包含：肥胖、長期使用雌激素製劑、糖尿病、高血壓、沒有生育、初經較早、停經較晚、與使用諾瓦得士錠（tamoxifen）。不正常的子宮出血是最主要的徵象，而大多數的子宮內膜癌婦女被診斷為疾病早期。手術治療是早期患者最主要的醫療處置，幸運的是，子宮內膜癌死亡率相對低，且五年存活率達81%。癌症治療後常伴隨合併症產生，如：不孕、手術性停經、下肢水腫、性功能障礙、焦慮與疲憊的現象，而這些合併常會影響婦女的生活品質。生活型態的改變，如：增加身體活動度及蔬果類食物的攝取，可以協助減緩合併症的症狀產生，並提升子宮內膜癌婦女的生活品質。

Endometrial cancer is the most common gynecological cancer and the sixth most common cancer among women in Taiwan. Risk factors for endometrial cancer include obesity, long-term estrogen replacement therapy, diabetes mellitus, hypertension, nulliparty, early age at menarche, late age at menopause, and tamoxifen therapy. Most women with endometrial cancer exhibit abnormal uterine bleeding. Endometrial cancer is often diagnosed at stage I. Surgery alone is the primary treatment for stage I endometrial cancer. Fortunately, mortality rates for endometrial cancer are relatively low, with a 5-year survival rate of 81% among women who are diagnosed with endometrial cancer in Taiwan. However, the common side effects of treatment, including infertility, surgical menopause, lymphedema of the lower extremities, sexual dysfunction, distress, and fatigue, impact significantly on the quality of life of patients. Lifestyle changes such as keeping physically active and eating a diet that is high in fruit and vegetables may alleviate symptoms and improve quality of life in women who have undergone treatment for endometrial cancer.

1. 國民健康署（2016a）．子宮內膜癌相對存活率．取自https://cris.hpa.gov.tw/pagepub/Home.aspx [Health Promotion Administration, Taiwan, ROC. (2016a). Relative survival rates for endometrial cancer. Retrieved from https://cris.hpa.gov.tw/pagepub/Home.aspx]
2. 國民健康署（2016b）．子宮內膜癌標準化發生率．取自https://cris.hpa.gov.tw/pagepub/Home.aspx [Health Promotion Administration, Taiwan, ROC. (2016b). Standardized incidences of endometrial cancer. Retrieved from https://cris.hpa.gov.tw/pagepub/Home.aspx]
3. 國民健康署（2015）．中華民國101 年癌症登記報告．取自http://www.hpa.gov.tw/BHPNet/Portal/File/StatisticsFile/201504290915220898/101年癌症登記年報.pdf [Health Promotion Administration, Taiwan, ROC. (2015). Cancer registry annual report, 2012 Taiwan. Retrieved from http://www.hpa.gov.tw/BHPNet/Portal/File/Statistics-File/201504290915220898/101年癌症登記年報.pdf]
4. The American College of Obstetricians and Gynecologists Committee on Gynecologic Practice. (2009, August). The role of transvaginal ultrasonography in the evaluation of postmenopausal bleeding. Retrieved from https://www.acog.org/-/media/Committee-Opinions/Committee-on-Gynecologic-Practice/co440.pdf?dmc=1&ts=20160803T0939030444
5. U.S. Department of Health and Human Services. (2015). Physical activity guidelines advisory committee report. Retrieved from http://health.gov/paguidelines/guidelines/chapter4.aspx
6. Ferlay, J., Bray, F., Forman, C., Mathers, C., & Parkin, D. M. (2010). GLOBOCAN 2008: Cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer.
7. Andrews, S.,von Gruenigen, V. E.(2013).Management of the late effects of treatments for gynecological cancer.Current Opinion in Oncology,25(5),566-570.
8. Bae, H. S.,Lim, M. C.,Lee, J. S.,Lee, Y.,Nam, B. H.,Seo, S.- S.,Park, S.-Y.(2016).Postoperative lower extremity edema in patients with primary endometrial cancer.Annals of Surgical Oncology,23(1),186-195.
9. Barakat, R. R.,Bundy, B. N.,Spirtos, N. M.,Bell, J.,Mannel, R. S.(2006).Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: A gynecologic oncology group study.Journal of Clinical Oncology,24(4),587-592.
10. Bohîlțea, R. E.,Ancăr, V.,Cristoiu, M. M.,Radoi, V.,Bohîlțea, L. C.,Furtunescu, F.(2015).Project for the national program of early diagnosis of endometrial cancer part I.Journal of Medicine and Life,8(3),305-314.
11. Bygdeman, M.,Swahn, M. L.(1996).Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women.Maturitas,23,259-263.
12. Carter, J.,Penson, R.,Barakat, R.,Wenzel, L.(2012).Contemporary quality of life issues affecting gynecologic cancer survivors.Hematology/Oncology Clinics of North America,26(1),169-194.
13. Chino, J. P.,Jones, E.,Berchuck, A.,Secord, A. A.,Havrilesky, L. J.(2012).The influence of radiation modality and lymph node dissection on survival in early-stage endometrial cancer.International Journal of Radiation Oncology *Biology*Physics,82(5),1872-1879.
14. Coukos, G.(Ed.),Rubin, S. C.(Ed.)(2005).Cancer of the uterus.New York, NY:Marcel Dekker.
15. Eldredge-Hindy, H. B.,Eastwick, G.,Anne, P. R.,Rosenblum, N. G.,Schilder, R. J.,Chalian, R.,Den, R.(2014).Adjuvant vaginal cuff brachytherapy for high-risk, early stage endometrial cancer.Journal of Contemporary Brachytherapy,6(3),262-270.
16. Felix, A. S.,Weissfeld, J. L.,Stone, R. A.,Bowser, R.,Chivukula, M.,Edwards, R. P.,Linkov, F.(2010).Factors associated with type I and type II endometrial cancer.Cancer Causes & Control,21,1851-1856.
17. Ferlay, J.,Soerjomataram, I.,Dikshit, R.,Eser, S.,Mathers, C.,Rebelo, M.,Bray, F.(2015).Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012.International Journal of Cancer,136(5),E359-E386.
18. Fisher, B.,Costantino, J. P.,Redmond, C. K.,Fisher, E. R.,Wickerham, D. L.,Cronin, W. M.(1994).Endometrial cancer in tamoxifen-treated breast cancer patients: Findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.JNCI: Journal of the National Cancer Institute,86(7),527-537.
19. Galaal, K.,Al Moundhri, M.,Bryant, A.,Lopes, A. D.,Lawrie, T. A.(2014).Adjuvant chemotherapy for advanced endometrial cancer.Cochrane Database of Systematic Reviews,5,CD010681.
20. Grube, W.,Ammon, T.,Killen, M. D.(2011).The role of ultrasound imaging in detecting endometrial cancer in postmenopausal women with vaginal bleeding.JOGNN: Journal of Obstetric, Gynecologic & Neonatal Nursing,40(5),632-637.
21. Jemal, A.,Bray, F.,Center, M. M.,Ferlay, J.,Ward, E.,Forman, D.(2011).Global cancer statistics.CA: A Cancer Journal for Clinicians,61(2),69-90.
22. Jim, H. S. L.,Jacobsen, P. B.,Phillips, K. M.,Wenham, R. M.,Roberts, W.,Small, B. J.(2013).Lagged relationships among sleep disturbance, fatigue, and depressed mood during chemotherapy.Health Psychology,32(7),768-774.
23. Jutzi, L.,Hoskins, P.,Lim, P.,Aquino-Parsons, C.,Tinker, A.,Kwon, J. S.(2013).The importance of adjuvant chemotherapy and pelvic radiotherapy in high-risk early stage endometrial carcinoma.Gynecologic Oncology,131,581-585.
24. Koutoukidis, D. A.,Knobf, M. T.,Lanceley, A.(2015).Obesity, diet, physical activity, and health-related quality of life in endometrial cancer survivors.Nutrition Review,73(6),399-408.
25. Lee, D. O.,Jung, M. H.,Kim, H. Y.(2011).Prospective comparison of biopsy results from curettage and hysteroscopy in postmenopausal uterine bleeding.The Journal of Obstetrics and Gynaecology Research,31(10),1423-1426.
26. Michaelson-Cohen, R.,Beller, U.(2009).Managing menopausal symptoms after gynecological cancer.Current Opinion in Oncology,21(5),407-411.
27. Morice, P.,Leary, A.,Creutzberg, C.,Abu-Rusturm, N.,Darai, E.(2016).Endometrial cancer.The Lancet,387(10023),1094-1108.
28. Nout, R. A.,Smit, V. T.,Putter, H.,Jurgenliemk-Schulz, I. M.,Jobsen, J. J.,Lutgens, L. C.,Creutzberg, C. L.(2010).Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): An open-label, non-inferiority, randomised trial.The Lancet,375(9717),816-823.
29. Ryan, A. J.,Susil, B.,Jobling, T. W.,Oehler, M. K.(2005).Endometrial cancer.Cell and Tissue Research,322(1),53-61.
30. Savelli, L.,Ceccarini, M.,Ludovisi, M.,Fruscella, E.,De laco, P. A.,Salizzoni, E.,Ferrandina, G.(2008).Preoperative local staging of endometrial cancer: Transvaginal sonography vs. magnetic resonance imaging.Ultrasound in Obstetrics & Gynecology,31(5),560-566.
31. Seo, Y. M.,Oh, H. S.,Seo, W. S.(2010).Causal relationships among factors associated with cancer-related fatigue.European Journal of Oncology Nursing,14(5),380-386.
32. Simon, E. B.(2014).Leg edema assessment and management.Medsurg Nursing,23(1),44-53.
33. Wright, J. D.,Jorge, S.,Tergas, A. I.,Hou, J. Y.,Burke, W. M.,Huang, Y.,Hershman, D. L.(2016).Utilization and outcomes of ovarian conservation in premenopausal women with endometrial cancer.Obstetrics & Gynecology,127(1),101-108.

1. 陳慧萱,高綺吟,林岑薰(2022)。運用舒適理論於一位子宮內膜癌末期病人之護理經驗。腫瘤護理雜誌，22(2)，103-113。
2. 葉惠玲,游淑幀(2022)。一位轉移性子宮內膜癌自殺病人之重症照護經驗。長庚護理，33(3)，112-120。